Showing 1 - 20 results of 27 for search 'Aneta Szudy-Szczyrek', query time: 0.06s
Refine Results
-
1
Description of invariant NKT cells. by Katarzyna Karwicka, Aneta Szudy-Szczyrek, Marek Hus
Published 2021-09-01
Article -
2
-
3
The role of immune checkpoint inhibitors in prostate cancer by Gabriel Surdacki, Aneta Szudy-Szczyrek, Aneta Gorący, Katarzyna Chyl-Surdacka, Marek Hus
Published 2019-03-01
Article -
4
-
5
Pleural Neoplasms—What Could MRI Change? by Michał Szczyrek, Paulina Bitkowska, Marta Jutrzenka, Aneta Szudy-Szczyrek, Anna Drelich-Zbroja, Janusz Milanowski
Published 2023-06-01
Article -
6
Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer by Michał Szczyrek, Radosław Mlak, Aneta Szudy-Szczyrek, Kamila Wojas-Krawczyk, Karolina Kędziora, Janusz Milanowski
Published 2022-03-01
Article -
7
-
8
<i>IL1B</i> Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients by Marcin Mazurek, Aneta Szudy-Szczyrek, Iwona Homa-Mlak, Marek Hus, Teresa Małecka-Massalska, Radosław Mlak
Published 2024-03-01
Article -
9
-
10
-
11
-
12
Polymorphisms in the Gene Encoding Caspase 8 May Predict the Response to First-Line Platinum-Based Chemotherapy in Locally Advanced or Advanced Non-Small-Cell Lung Cancer by Michał Szczyrek, Radosław Mlak, Aneta Szudy-Szczyrek, Karolina Kędziora, Teresa Małecka-Massalska, Paweł Krawczyk, Janusz Milanowski
Published 2021-03-01
Article -
13
-
14
Spinal manifestation of Multiple Myeloma - case report by Jakub Litak, Aneta Szudy-Szczyrek, Cezary Grochowski, Witold Janusz, Piotr Kamieniak, Katarzyna Kot-Bakiera, Dariusz Szczepanek
Published 2017-02-01
Article -
15
Spinal manifestation of Multiple Myeloma - case report by Jakub Litak, Aneta Szudy-Szczyrek, Cezary Grochowski, Witold Janusz, Piotr Kamieniak, Katarzyna Kot-Bakiera, Dariusz Szczepanek
Published 2017-02-01
Article -
16
-
17
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma by Szymon Zmorzynski, Magdalena Wojcierowska-Litwin, Sylwia Popek-Marciniec, Aneta Szudy-Szczyrek, Wojciech Styk, Sylwia Chocholska, Agata Anna Filip
Published 2021-11-01
Article -
18
Efficacy of ixazomib-lenalidomide-dexamethasone in high-molecular-risk relapsed/refractory multiple myeloma – case series and literature review by Aneta Szudy-Szczyrek, Sylwia Chocholska, Oliwia Bachanek-Mitura, Olga Czabak, Radosław Mlak, Michał Szczyrek, Justyna Muzyka-Kasietczuk, Marek Hus
Published 2021-06-01
Article -
19
-
20
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Ac... by Szymon Zmorzynski, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
Published 2024-03-01
Article